NKIRAS2 and nasopharyngeal carcinoma: NF- κB inhibitor interacting Ras-like 2(NKIRAS2), a negative regulator of the NF- κB signaling, was identified to be a direct target of miR-BART13 in nasopharyngeal carcinoma (NPC) cells, and promoted nasopharyngeal carcinoma cell growth (Xu et al., 2019).